Literature DB >> 8614289

Relationship between cAMP induced inhibition of human meningioma cell proliferation and autocrine secretion of interleukin-6.

A Hüttner1, T Lei, R Fahlbusch, W Schrell, E F Adams.   

Abstract

Previous studies have suggested that activation of the adenylyl cyclase - cAMP system in meningiomas results in decreased mitosis. We have used meningioma cell culture to further investigate this phenomenon and to examine the potential role played by interleukin-6 (IL6). Incubation of cultured meningioma cells for 4-6 days with cholera toxin and theophylline, both of which increase intracellular cAMP levels, markedly stimulated IL6 secretion and inhibited cell growth rate. Similar effects were observed with 8-bromo-cAMP. In contrast, a neutralising polyclonal antibody against IL6 significantly stimulated meningioma proliferation and reduced the inhibitory effects of 8-bromo-cAMP. These results support the concept that IL6 acts as an autocrine / paracrine inhibitory factor for meningioma proliferation, and that the inhibition exerted by elevated intracellular cAMP levels may be at least partially mediated via increased secretion of the cytokine.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8614289     DOI: 10.1016/0024-3205(96)00098-7

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  3 in total

1.  The regulatory effects of protein kinase C on the proliferation of cultured human low-passage meningioma cells.

Authors:  B Huang; T Lei; K Liu; L Zhang; L Li; Z Zhang; D Xue
Journal:  J Tongji Med Univ       Date:  2000

2.  Etk/Bmx, a tyrosine kinase with a pleckstrin-homology domain, is an effector of phosphatidylinositol 3'-kinase and is involved in interleukin 6-induced neuroendocrine differentiation of prostate cancer cells.

Authors:  Y Qiu; D Robinson; T G Pretlow; H J Kung
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205

3.  Protein Kinase A Distribution in Meningioma.

Authors:  Antonio Caretta; Luca Denaro; Domenico D'Avella; Carla Mucignat-Caretta
Journal:  Cancers (Basel)       Date:  2019-10-29       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.